|

PHIN-214 Subcutaneous injection Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Terlipressin derivative

Pipeline

Phase 1: 1

Top Sponsors

  • PharmaIN1

Indications

  • Ascites Hepatic1
  • Liver Disease1
  • Liver Fibrosis1
  • Cirrhosis, Liver1

Chandler, Arizona1 trial

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

Arizona Liver Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.